Back
Dermata Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
DRMA
Dermata Therapeutics
Last Price:
1.11
Seasonality Move:
-57.39%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.
Dermata Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.27 | Sell |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 3.39 | Sell |
| 8-day EMA: | 1.17 | Sell |
| 20-day EMA: | 1.26 | Sell |
| 50-day EMA: | 1.45 | Sell |
| 200-day EMA: | 6.23 | Sell |
Dermata Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 39.31 | Sell |
| Chaikin Money Flow: | -22154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.47) | Sell |
| Bollinger Bands (100): | (1.3 - 2.18) | Sell |
Dermata Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 1.15 while DRMA 8-day simple moving average is 1.16, which is a Sell signal.
- The stock price of DRMA is 1.15 while Dermata Therapeutics 20-day SMA is 1.27, which makes it a Sell.
- Dermata Therapeutics 50-day simple moving average is 1.45 while DRMA share price is 1.15, making it a Sell technically.
- DRMA stock price is 1.15 and Dermata Therapeutics 200-day simple moving average is 3.39, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a Sell
The current Dermata Therapeutics [DRMA] share price is $1.15. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
2.35M
Price in USD:
1.15
Share Volume:
77.54K
Dermata Therapeutics 52-Week Range
52-Week High:
13.35
52-Week Low:
1.05
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?
The Dermata Therapeutics stock price is 1.15 USD today. -
Will DRMA stock go up or go down?
Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dermata Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is overvalued.
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 1.15 while DRMA 8-day exponential moving average is 1.17, which is a Sell signal.
- The stock price of DRMA is 1.15 while Dermata Therapeutics 20-day EMA is 1.26, which makes it a Sell.
- Dermata Therapeutics 50-day exponential moving average is 1.45 while DRMA share price is 1.15, making it a Sell technically.
- DRMA stock price is 1.15 and Dermata Therapeutics 200-day simple moving average is 6.23, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
- DRMA Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Dermata Therapeutics is a Sell
- Dermata Therapeutics Relative Strength Index (RSI) is 39.31, which suggest Dermata Therapeutics is oversold
- The Bollinger Bands (25) for Dermata Therapeutics is (1.17 - 1.47), which suggest Dermata Therapeutics is a Sell
- The Bollinger Bands (100) for Dermata Therapeutics is (1.3 - 2.18), which suggest Dermata Therapeutics is a Sell
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.